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Abstract
Background: Lead (Pb) exposure during pregnancy may increase the risk of adverse maternal, infant, or childhood
health outcomes by interfering with hypothalamic-pituitary-adrenal-axis function. We examined relationships
between maternal blood or bone Pb concentrations and features of diurnal cortisol profiles in 936 pregnant
women from Mexico City.
Methods: From 2007–11 we recruited women from hospitals/clinics affiliated with the Mexican Social Security
System. Pb was measured in blood (BPb) during the second trimester and in mothers’ tibia and patella 1-month
postpartum. We characterized maternal HPA-axis function using 10 timed salivary cortisol measurements collected
over 2-days (mean: 19.7, range: 14–35 weeks gestation). We used linear mixed models to examine the relationship
between Pb biomarkers and cortisol area under the curve (AUC), awakening response (CAR), and diurnal slope.
Results: After adjustment for confounders, women in the highest quintile of BPb concentrations had a reduced
CAR (Ratio: −13%; Confidence Interval [CI]: −24, 1, p-value for trend< 0.05) compared to women in the lowest
quintile. Tibia/patella Pb concentrations were not associated with CAR, but diurnal cortisol slopes were suggestively flatter
among women in the highest patella Pb quantile compared to women in the lowest quantile (Ratio: 14%; CI: −2, 33).
BPb and bone Pb concentrations were not associated with cortisol AUC.
Conclusions: Concurrent blood Pb levels were associated with cortisol awakening response in these pregnant women
and this might explain adverse health outcomes associated with Pb. Further research is needed to confirm these results
and determine if other environmental chemicals disrupt hypothalamic-pituitary-adrenal-axis function during pregnancy.
Keywords: Lead, Cortisol, Epidemiology, Pregnancy
Introduction
The hypothalamic-pituitary-adrenal (HPA) axis is re-
sponsible for the regulation of cortisol production in
humans. Cortisol plays a major role in neurogenesis and
is critical to brain development, especially in memory for-
mation, with the hippocampus being the brain region with
the highest concentration of glucocorticoid receptors
[1,2]. In humans, cortisol exhibits a diurnal secretory pat-
tern, where levels sharply increase in the first hour after
awakening and slowly decline across the day till evening.
HPA-axis function can be measured by examining the di-
urnal pattern of salivary cortisol concentrations and
changes in these patterns are associated with health and
disease [3–6]. Some studies suggest that alterations in ma-
ternal HPA-axis function during pregnancy are associated
with neurobehavioral deficits [7–9].
Gestational Pb exposure is a well-known risk factor for
adverse infant, child, and adult behavioral and cognitive
development [10,11]. Animal and human studies suggest
that lead (Pb) exposure may be associated with alterations
in HPA-axis function, where increased Pb exposure is
associated with altered adrenocortical response to acute
stressors [12–16]. Thus, the toxic effects of Pb may be
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function.
Despite the known role that Pb and cortisol play in
brain development, the relationship between Pb and cor-
tisol demonstrated in animals, and potential for maternal
HPA-axis disruptions to impact child development, we
are not aware of any animal or epidemiological studies
that have evaluated associations between Pb exposure
and ambulatory diurnal cortisol patterns. Thus, we in-
vestigated the relationship between maternal bone or
blood Pb levels and salivary cortisol concentrations dur-
ing pregnancy in a cohort of Mexico City women to
determine if cumulative or recent Pb exposure was asso-
ciated with altered diurnal cortisol profiles or daily corti-
sol production.
Methods
Participants
Participants for this study were enrolled from an ongoing
prospective birth cohort in Mexico City. Between July
2007 and February 2011, we invited pregnant women re-
ceiving health insurance and prenatal care through the
Mexican Social Security System (IMSS) to participate in
our study. The IMSS is funded by the federal government,
employers, and employees to provide health care to
private-sector employees and low- to middle-class workers
and their families.
To be eligible for participation in the study, women
had to be <20 weeks gestation, ≥18 years old, free of
heart or kidney disease, have access to a telephone, plan
to reside in Mexico City for the next 3 years, not use ste-
roids (including glucocorticoids) or anti-epilepsy drugs,
and not consume alcohol on a daily basis. Institutional re-
view boards at the Harvard School of Public Health, Icahn
School of Medicine at Mount Sinai, and Mexican National
Institute of Public Health. All women provided informed
consent after study protocols were explained to them by
research staff.
Blood Pb measurements
Venous blood was collected in trace metal free tubes
from women upon study enrollment during the 2nd tri-
mester, briefly refrigerated at 2-6°C, and subsequently
frozen at -20°C until analyzed for Pb using graphite fur-
nace atomic absorption spectrophotometry (Model 3000:
Perkin Elmer, Wellesley, MA, USA) [17]. Analysis of
blinded quality control samples provided by the Mater-
nal and Child Health Bureau and the Wisconsin State
Laboratory of Hygiene Cooperative Blood Lead Profi-
ciency Testing Program demonstrated good precision
and accuracy. The limit of detection for this method is
<1 µg/dL and the instrument precision is approximately
1 µg/dL. Blood Pb concentrations were examined as
continuous variables (µg/dL) and in quintiles.
Bone Pb measurements
Tibia (cortical bone) and patella (trabecular bone) bone
Pb concentration measurements were obtained ~1 month
postpartum (mean: 34 days, range: 26–55) using a K-shell
X-ray fluorescence instrument [18]. The patella and mid-
tibial shaft of each leg were measured for 30 minutes and
measures from each leg were averaged by the inverse of
the measurement variance. Patella and tibia bone Pb mea-
surements are thought to reflect Pb exposures over the
span of decades, with tibia measurements reflecting longer
time spans [19]. Bone Pb levels as low as 0.3µg/g can be
quantified using K-XRF; however negative values are
sometimes observed when the true bone Pb level is close
to 0 [20]. In order to best accommodate these negative
values, we created five bone Pb concentration categories
where the reference category was all values <2µg/g and
four additional categories were based on quartiles of
the values≥2µg/g. Retaining negative values has been
shown to be the least-biased method to accommodate
left-censored data, including bone Pb measurements
[20,21]. The average imprecision (±SD) of patella and tibia
Pb values were 6.4 (±2.3) and 6.9 (±2.3) µg/g, respectively.
Salivary cortisol measurements
Saliva sampling provides a non-invasive measure of HPA-
axis function [3]. Between 14 and 35 weeks gestation
(mean: 19.7, standard deviation [SD]: 2.4 weeks), pregnant
women were given verbal and written instruction describ-
ing when and how to provide five saliva samples each day
over two consecutive days during the week or weekend.
Before collecting samples, research staff demonstrated
what times of the day women should collect their samples
and how they should complete their sample collection
diary. Women were instructed to provide samples into
Salicaps (IBL International, Hamburg, Germany) using the
passive drool technique upon awakening, 45 minutes after
waking, 4 hours after waking, 10 hours after waking, and
at bedtime. Participants were instructed not to eat, brush
their teeth, or drink liquids for at least 15 minutes before
providing a sample and not drink caffeinated beverages
before collecting the first two samples. After sample col-
lection, women recorded the collection time on the tube
and in their diary, and were asked to refrigerate samples
until pickup, after which they were stored at −70°C until
shipment to Dresden, Germany on dry ice.
Saliva samples were assayed in the same batch in
duplicate for cortisol using a chemi-luminescence-assay
with sensitivity of ~0.16 ng/ml (IBL; Hamburg, Germany,
Clemens Kirschbaum). Control sera covering at least three
levels of cortisol were run during each 24-hour time
period and intra- and interassay coefficients of variation
were less than 8%.
Salivary cortisol concentrations exhibit a diurnal rhythm,
rising very quickly after waking and then falling throughout
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duction and two features of women’s diurnal cortisol pat-
terns. The area under the curve (AUC) of the observed
salivary cortisol levels is an approximation of total daily
cortisol production. It was computed using the trapezoidal
r u l ea n ds t a n d a r d i z e dt ot h em e a nv a l u et h a ta l lw o m e ni n
the study spent awake each day (~15 hours) [3]. The rapid
increase in cortisol concentrations in the morning, known
as the cortisol awakening response (CAR) was estimated
from the change in cortisol concentrations between the
first and second saliva samples of each day. The decline in
concentrations over the course of the day is known as diur-
nal rhythm and was estimated using the change in salivary
cortisol concentrations between the 1st and 5th samples of
each day.
Covariates
We considered covariates that might be associated with
both maternal Pb exposure and salivary cortisol concen-
trations [3,22]. Maternal age, marital status, years of
education, parity, and smoking status (never, former, and
current) was collected using standardized questionnaires.
The week cortisol sample collection during pregnancy
was calculated based on date of last menstrual period.
Weight and height were measured at the baseline study
visit and used to calculate body mass index (BMI). We
measured calf-circumference with a tape measure at the
1 month postpartum visit and adjusted for it in bone Pb
models.
We also collected information on stress or depressive
symptoms, although we did not adjust for these in our
primary models since this information was collected in
the 3rd trimester and these symptoms may be a causal
intermediate between Pb exposure and cortisol [23].
Maternal stress was assessed using the Crisis in Family
Systems-Revised survey, which inquires about 11 life
event domains experienced in the last 6 months (finances,
legal problems, career, home events, relationships, safety
in the home, safety in the neighborhood, personal medical
issues, medical issues with others, prejudice, and authority
figures/institutions) [24]. A summary score (range 0 to 11)
was calculated by summing the number of domains that
women endorsed as having at least one negative life event.
We measured depressive symptoms using the Edinburgh
Postnatal Depression Scale [25].
Statistical analyses
Given their right-skewed distribution, all cortisol mea-
sures were log10-transformed. We used linear mixed
models with random intercepts for day and participant,
assuming an unstructured covariance matrix to account
for the within-woman correlation of cortisol concentra-
tions within and across days [26]. To visualize patterns of
cortisol response over the course of a day, we modeled
cortisol concentrations as a function of hours since waking
using a five-knot restricted cubic polynomial spline [27].
We created smoothed plots according to quantiles of
blood and bone Pb concentration to visually assess the im-
pact of Pb on cortisol rhythms.
We report the percent difference in cortisol AUC ac-
cording to Pb exposure categories. To estimate the
association between Pb and CAR, we modeled salivary
cortisol concentrations at the first and second samples
as a function of time since waking (hours), Pb levels,
their interaction, and covariates. We examined the diur-
nal slope using the first and fifth saliva samples and the
same approach used for the CAR. We report the percent
change in cortisol per hour according to Pb levels and
the beta coefficient of the ratio of these percent changes
in cortisol per hour according to Pb levels. We restricted
these two analyses to women who reported collecting
their samples in the a prior defined sampling windows
since salivary cortisol concentrations change rapidly in
the first hour after waking and incorrectly timed samples
can misclassify cortisol profiles (see Additional file 1:
Table S1 for a priori defined windows) [28].
Secondary analyses
We conducted a secondary analysis adjusting for 3rd
trimester maternal stress and depressive symptoms, the
day of the week (weekday vs. weekend), the time of
awakening, or number of hours slept on the prior night.
We also examined diurnal slopes using the 1st, 3rd, 4th,
and 5th salivary cortisol concentrations collected each
day. Finally, we re-conducted our tibia and patella Pb
analyses after excluding women whose bone Pb mea-
surements imprecision values were >10 (n =48-53) and
15 (n =1) µg/g, respectively.
Results
A total of 1,054 women enrolled in our study during
their 2nd trimester of pregnancy. Of these, 937 women
provided at least one day of valid cortisol samples. We
excluded one woman who had 4 out of the 10 highest
cortisol values in the entire cohort. A total of 9,183 sal-
iva samples were provided by the remaining 936 women.
With the exception of former-smoking (33.8 vs. 39.8%)
and marital status (57.4 vs. 47.5% married), women in-
cluded in our analyses were similar to the 118 women
not included. Our primary blood Pb analyses included
873-918 women with complete data and our bone Pb
analyses included 568-594 women with complete data.
On average, women were 28 years of age, modestly ed-
ucated (mean: 12 years), married (57%), had no children
or one child (74%), and never smokers (66%) (Table 1).
A total of 199 women (21.3%) had blood Pb concentra-
tions greater than 5 µg/dL and 34 (3.6%) had concentra-
tions greater than 10 µg/dL. Log10-transformed blood Pb
Braun et al. Environmental Health 2014, 13:50 Page 3 of 10
http://www.ehjournal.net/content/13/1/50concentrations were modestly correlated with tibia (Pearson
R=0.26, p< 0.001) and patella (Pearson R=0.37, p< 0.001)
Pb concentrations. Patella and tibia Pb concentrations
were modestly correlated as well (Pearson R=0.38, p<
0.001).
As expected, salivary cortisol concentrations exhibited
a diurnal shape over the course of the day, where they
were highest in the hour after awakening, then de-
creased steeply in the next 5 hours after waking with the
slope flattening across the later 10 hours of the day
(Additional file 1: Figure S1).
Salivary cortisol AUC concentrations did not vary with
blood or bone Pb concentrations (Table 2), although the
cortisol AUC was suggestively higher among women in
the two highest quantiles of patella Pb.
Salivary cortisol concentrations increased 5-7% during
the first hour of the day among women in the 1st, 2nd,
and 3rd quintiles of blood Pb concentrations, but de-
creased 5 and 8% among women in the 4th and 5th
quintiles, respectively (Table 3 and Figure 1). The CAR
among women in the fourth (β: −0.04; 95% confidence
interval [CI]: −0.11, 0.02) and fifth (β: −0.06; 95% CI: −0.12,
0.0) quintiles were lower than women in the first
quintile. There was not a consistent pattern of relation-
ships between bone Pb concentrations and CAR slopes
(Figure 2).
Table 1 Univariate description of demographic characteristics, bone/blood Pb concentrations, and cortisol sample
characteristics of 936 Mexico City pregnant women (2007–2011)
Variable N (%) Mean (SD) Min, Max
Maternal Age 27.8 (5.5) 18.0, 44.0
Maternal Education 11.9 (2.9) 0.0, 21.0
Maternal Weight 64.7 (11.0) 40.0, 108.0
Maternal Height 1.6 (0.1) 1.4, 1.8
Maternal BMI (kg/m
2) 26.9 (4.2) 17.4, 44.7
Weeks Gestation at Cortisol Collection 19.7 (2.4) 14.1, 35.1
Calf Circumference at 1-Month visit (cm) 33.6 (3.2) 25.0, 47.0
Negative Life Events Score 3.1 (2.1) 0.0, 11.0
Edinburgh Postnatal Depression Scale Score 8.4 (5.6) 0.0, 28.0
Maternal 2nd Trimester Blood Pb Concentration (µg/dL) 3.7 (2.7) 0.5, 23
Maternal Tibia Pb Concentration (µg/g) 2.7 (8.4) ND, 20
Maternal Patella Pb Concentration (µg/g) 4.6 (8.6) ND, 43
Waking Time (SD in minutes) 0747 (83) 0305-1300
Hour of Sleep (hours)
1 8.3 (1.6) 0.0, 14.5
Marital Status
Married 537 (57.4) 537 (57.4)
Free Union 226 (24.1) 226 (24.1)
Single/Divorced/Separated 173 (18.5) 173 (18.5)
Number of prior children
1 356 (38.0) 356 (38.0)
2 339 (36.2) 339 (36.2)
3 175 (18.7) 175 (18.7)
4+ 66 (7.1) 66 (7.1)
Smoking Status During Pregnancy
Never 614 (65.6) 614 (65.6)
Former 316 (33.8) 316 (33.8)
Current 6 (0.6) 6 (0.6)
Weekday Cortisol Collection
1
No 333 (35.6) 333 (35.6)
Yes 603 (64.4) 603 (64.4)
ND: Not detectable.
1-On first day of collection.
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tiles of blood Pb concentrations (Table 4 and Figure 1).
Women in the top quantile of tibia Pb concentrations
had flatter diurnal slopes (74% decline per 15 hours)
than women with tibia Pb concentration <2 µg/g (77%
decline per 15 hours), but the 95% confidence interval
(CI) for this difference included the null value (β: 0.04;
CI: −0.03, 0.11). A similar pattern was seen when com-
paring women in the top (−73% decline per 15 hours)
and bottom (−77% decline per 15 hours) quantiles of pa-
tella Pb concentrations (β: 0.06; CI: −0.01, 0.12), but this
difference did not reach conventional levels of statistical
significance.
Secondary analyses
Adjusting for 3rd trimester stress or depressive symp-
toms, time of waking, and hours of sleep did not sub-
stantively change the pattern of most of our results
(subset of 709 women). The pattern of results for diurnal
slopes was similar regardless of whether we used
2 or 5 samples to characterize the diurnal slope. Our re-
sults were not substantively changed when we excluded
women with relatively imprecise bone Pb measurements
(results not shown).
Discussion
Among pregnant women from Mexico City, second
trimester salivary cortisol concentrations followed the ex-
pected diurnal pattern, demonstrating that our study
protocol was successful in capturing cortisol daily rhythms.
Characteristics of this diurnal pattern differed according to
blood and bone Pb concentrations after adjusting for
demographic and anthropometric characteristics suggest-
ing that Pb exposure could alter cortisol rhythms. How-
ever, associations between bone Pb concentrations and
diurnal cortisol rhythms did not reach convention levels of
statistical significance.
The use of multiple Pb exposure biomarkers allowed
us to finely dissect this relationship with respect to dif-
ferent windows of exposure. The association between Pb
exposure and salivary cortisol rhythms depended on the
Pb exposure measurement matrix. This is intriguing
given that these two matrices represent different sources
and timing of Pb exposure. Blood Pb levels are corre-
lated with the pool of biologically active Pb and repre-
sent recently ingested or inhaled Pb, as well as Pb
released from the skeleton [19]. In contrast, bone Pb
represents past Pb exposures, including those from de-
cades ago, that have been deposited into hydroxyapatite
Table 2 Adjusted change in cortisol area under the curve (AUC) according to blood, tibia, and patella Pb
concentrations in Mexico City women (2007–2011)
Pb biomarker/quantile N GM salivary cortisol AUC (nmol-hours) % Difference in cortisol AUC nmol-hours (95% CI)
Blood Pb
1
Quintile 1 (0-<1.8µg/dL) 185 82.0 Ref
Quintile 2 (1.8-< 2.4µg/dL) 183 88.6 8 (−1, 18)
Quintile 3 (2.4-< 3.4µg/dL) 184 89.8 9 (0, 19)
Quintile 4 (3.4-< 5.1µg/dL) 182 88.8 8 (−1, 18)
Quintile 5 (≥5.1µg/dL) 184 83.8 2 (−6, 12)
Continuous, per 2.5µg/dL 918 −1( −4, 1)
Tibia Pb
2
Quantile 1 (<2µg/g) 266 87.8 Ref
Quantile 2 (2-< 4.3µg/g) 82 83.2 −5( −14, 5)
Quantile 3 (4.3-<6.7 µg/g) 82 89.3 2 (−8, 13)
Quantile 4 (6.7-<11.1µg/g) 82 87.5 0 (−10, 10)
Quantile 5 (≥11.1µg/g) 82 93.4 6 (−4, 18)
Patella Pb
2
Quantile 1 (<2µg/g) 241 86.6 Ref
Quantile 2 (2-< 4.5µg/g) 86 87.6 1 (−8, 12)
Quantile 3 (4.5-<7.8 µg/g) 87 81.8 −6( −14, 4)
Quantile 4 (7.8-<12.7µg/g) 86 97.0 12 (1, 24)
Quantile 5 (>12.7-43.2µg/g) 87 90.3 4 (−6, 16)
GM: Geometric Mean, AUC: Area Under the Curve.
1-Adjusted for maternal age (continuous years), education (continuous years), body mass index (continuous), marital status (married, free union, or single/
separated/divorced), gestational age at time of cortisol collection (continuous weeks), parity (1, 2, 3, or 4+), and maternal smoking status during pregnancy
(never, former, or current).
2-Adjusted for above covariates and maternal calf circumference at 1-month postpartum.
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women (2007–2011)
1
Pb biomarker/quantile % Change in cortisol per hour (95% CI) β Coefficient (95% CI)
Blood Pb (n=873)
2
Quintile 1 (0-<1.8µg/dL) 5 (−5, 16) Ref
Quintile 2 (1.8-< 2.4µg/dL) 5 (−5, 16) 0.00 (−0.06, 0.06)
Quintile 3 (2.4-< 3.4µg/dL) 7 (−4, 18) 0.01 (−0.05, 0.07)
Quintile 4 (3.4-< 5.1µg/dL) −5( −14, 5) −0.04 (−0.11, 0.02)
Quintile 5 (≥5.1µg/dL) −8( −16, 2) −0.06 (−0.12, 0.00)
Continuous, per 2.5µg/dL N/A −0.02 (−0.04, 0.00)
Tibia Pb (n= 575)
3
Quantile 1 (<2µg/g) 4 (−4, 12) Ref
Quantile 2 (2-< 4.3µg/g) −8( −21, 7) −0.05 (−0.12, 0.03)
Quantile 3 (4.3-<6.7 µg/g) 7 (−7, 23) 0.02 (−0.05, 0.09)
Quantile 4 (6.7-<11.1µg/g) −9( −22, 5) −0.05 (−0.12, 0.02)
Quantile 5 (≥11.1µg/g) 8 (−7, 25) 0.02 (−0.05, 0.09)
Patella Pb (n= 568)
3
Quantile 1 (<2µg/g) 2 (−6, 10) Ref
Quantile 2 (2-< 4.5µg/g) 11 (−3, 27) 0.04 (−0.03, 0.11)
Quantile 3 (4.5-<7.8 µg/g) −11 (−22, 3) −0.05 (−0.12, 0.02)
Quantile 4 (7.8-<12.7µg/g) −2( −15, 12) −0.01 (−0.08, 0.06)
Quantile 5 (>12.7-43.2µg/g) 7 (−7, 23) 0.03 (−0.04, 0.10)
1-Only includes women who collected their first and second cortisol samples in the correct time window.
2-Salivary cortisol concentrations are modeled as a function of time since waking, Pb biomarker, a Pb biomarker x time interaction term, and covariates.
3-Adjusted for above covariates and maternal calf circumference at 1-month postpartum.
Figure 1 Adjusted geometric mean salivary cortisol concentrations as a function of time since waking according to 2nd trimester
blood Pb quintile
1. 1-Smoothed function was derived by modeling the time since waking as a restricted cubic polynomial spline with 918
women’s salivary cortisol concentrations as the outcome. Only samples collected in the correct time windows are included in this plot. The model
was adjusted for maternal age (continuous years), education (continuous years), body mass index (continuous), marital status (married, free union,
or single/separated/divorced), gestational age at time of cortisol collection (continuous weeks), parity (1, 2, 3, or 4+), and maternal smoking status
during pregnancy (never, former, or current).
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http://www.ehjournal.net/content/13/1/50Figure 2 Adjusted geometric mean salivary cortisol concentrations as a function of time since waking according to 1-month
postpartum patella Pb quantile
1. 1-Smoothed function was derived by modeling the time since waking as a restricted cubic polynomial spline
with 594 women’s salivary cortisol concentrations as the outcome. Only samples collected in the correct time windows are included in this plot.
The model was adjusted for maternal age (continuous years), education (continuous years), body mass index (continuous), marital status (married,
free union, or single/separated/divorced), gestational age at time of cortisol collection (continuous weeks), parity (1, 2, 3, or 4+), and maternal
smoking status during pregnancy (never, former, or current).
Table 4 Adjusted change in cortisol diurnal slope according to blood, tibia, and patella Pb concentrations in Mexico
City women from 2007-2011
1
Pb biomarker/quantile % Change in cortisol per 15 hours (95% CI) β Coefficient (95% CI)
Blood Pb (n=918)
2
Quintile 1 (0-<1.8µg/dL) −77 (−79, −75) Ref
Quintile 2 (1.8-< 2.4µg/dL) −77 (−79, −75) 0.00 (−0.06, 0.05)
Quintile 3 (2.4-< 3.4µg/dL) −76 (−78, −73) 0.03 (−0.03, 0.08)
Quintile 4 (3.4-< 5.1µg/dL) −76 (−78, −73) 0.02 (−0.03, 0.08)
Quintile 5 (≥5.1µg/dL) −78 (−79, −75) −0.01 (−0.06, 0.05)
Continuous, per 2.5µg/dL N/A 0.00 (−0.02, 0.02)
Tibia Pb (n= 594)
3
Quantile 1 (<2µg/g) −77 (−79, −76) Ref
Quantile 2 (2-< 4.3µg/g) −79 (−82, −76) −0.05 (−0.11, 0.02)
Quantile 3 (4.3-<6.7 µg/g) −77 (−79, −73) 0.00 (−0.07, 0.07)
Quantile 4 (6.7-<11.1µg/g) −77 (−80, −74) −0.01 (−0.08, 0.06)
Quantile 5 (≥11.1µg/g) −74 (−78, −71) 0.04 (−0.03, 0.11)
Patella Pb (n= 587)
3
Quantile 1 (<2µg/g) −78 (−79, −76) Ref
Quantile 2 (2-< 4.5µg/g) −77 (−80, −74) −0.01 (−0.08, 0.05)
Quantile 3 (4.5-<7.8 µg/g) −77 (−80, −74) −0.01 (−0.08, 0.05)
Quantile 4 (7.8-<12.7µg/g) −79 (−81, −76) −0.04 (−0.11, 0.03)
Quantile 5 (>12.7-43.2µg/g) −73 (−76, −69) 0.06 (−0.01, 0.12)
1-Only includes women who collected their first and second cortisol samples in the correct time window.
2-Salivary cortisol concentrations are modeled as a function of time since waking, Pb biomarker, a Pb biomarker x time interaction term, and covariates.
3-Adjusted for above covariates and maternal calf circumference at 1-month postpartum.
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ing different periods and sources of exposure, we ob-
served modest correlations between bone and blood Pb
concentrations. We speculate that past or concurrent Pb
exposures – represented by bone and blood Pb levels,
respectively – could have different effects on HPA-axis
function.
Specific periods of vulnerability have been identified in
prior studies of Pb exposure and child cognition [29],
but little is known about the potential associations
between Pb exposures at different periods of life and
HPA-axis function. Pb exposures earlier in pregnancy
or before pregnancy could impact maternal HPA-axis
function and future studies should consider additional
windows of vulnerability (e.g., 1st trimester). Alterna-
tively, specific pattern of associations could result from
pregnancy-induced changes in bone Pb mobilization,
bone turnover, and HPA-axis function [30–32].
We are not aware of other studies examining the rela-
tionship between environmental chemical exposures and
daily diurnal cortisol patterns in any human populations.
Two previous studies have examined the relationship be-
tween blood/bone Pb concentrations and the response
to an acute adrenocortical stressor response in children
and adults [12,13]. Gump et al. found that elevated ges-
tational and childhood blood Pb concentrations were as-
sociated with heightened cortisol responses in children
following an acute stressor task [12]. Fortin and col-
leagues found the opposite association in a group of oc-
cupationally exposed men [13]. In their study, bone and
blood Pb concentrations were associated with increased
adrenocorticotropic hormone (ACTH) concentrations
and decreased cortisol concentrations before the applica-
tion of an acute stressor and increased ACTH: cortisol
ratios after stressor application, suggesting that Pb expos-
ure may be associated with adrenal hypo-responsiveness to
pituitary stimulation. Consistent with this, experimental
studies in rats suggest that Pb exposure is associated with
elevated corticosterone concentrations during pregnancy
[16]. Studies of adult rodents found that Pb exposure was
associated with elevated ACTH and corticosterone con-
centrations, as well as increased anxiety-like behaviors [14].
The presented results and prior epidemiological stud-
ies illustrate potentially important differences in HPA-
axis function response to Pb exposure that may depend
on the choice of measure for HPA-axis function (e.g.,
acute stressor vs. diurnal rhythm) and timing of Pb ex-
posure. The latter is important for fetal development
since disruption of homeostatic cortisol function during
the sensitive prenatal period may have profound effects
later in life since the developing fetus is more sensitive
to environmental exposures [33]. Changes in maternal
cortisol levels during gestation could alter placental ex-
pression of enzymes involved in glucocorticoid signaling
and metabolism, ultimately leading to altered neurobe-
havior [8,9].
Both gestational Pb and stress exposure may increase the
risk of poorer mental and physical development, reduced
IQ, and delinquent behavior in children [7,10,34, 35]. The
neurotoxic mechanisms of Pb exposure are diverse and
may be outcome dependent and the association between
Pb and HPA-axis function has been relatively unstudied as
a potential mechanism of Pb toxicity [36]. A prior study
found that higher maternal 3rd trimester serum cortisol
levels were associated with lower child IQ [7]. While this
finding may seem discordant with our finding of reduced
CAR among women with elevated blood Pb levels, the
cortisol measures in this and the prior study reflect differ-
ent features of HPA-axis function. The CAR is the change
in cortisol over the first hour of the day, while a single
serum measurement assesses cortisol concentrations at
one time during the day. Additional studies will need to
address the relationships between Pb, diurnal cortisol
rhythms, and child neurodevelopment to determine if
alterations in HPA-axis function are a mediator of Pb-
induced cognitive deficits. Future studies should also iden-
tify which patterns of maternal diurnal cortisol rhythms
during pregnancy are associated with adverse child
neurodevelopment.
While salivary cortisol concentrations are a non-invasive
method of measuring HPA-axis function, there are sources
of variability that may impact the accuracy and precision
of our results. First, cortisol exhibits both within-day and
within-person variability that we attempted to reduce and
account for the by collecting 10 timed samples across two
days and using appropriate statistical models. Second, ac-
curate estimation of the CAR and diurnal slope requires
t h a tt h et i m eo fs a l i v as a m p l ec o l l e c t i o nb er e p o r t e dc o r -
rectly. Seventy-percent of women who reported collecting
their cortisol samples in the acceptable time windows had
at least one day with a positive CAR. This is similar to
prior studies reporting that 75% of persons have increasing
cortisol concentrations after awakening [37]. Incorrectly
reported times of waking or 1st and 2nd sample collection
could produce a negative CAR that is not due to biological
variation, but measurement error. This could systematically
bias our results if socioeconomic factors associated with Pb
exposure are also associated with protocol adherence; how-
ever, we have no reason to suspect this is the case [38].
Residual confounding may have produced the pattern
of results we observed. For instance, women with more
Pb exposure may live in poorer neighborhoods with
higher crime, resulting in changes in the pattern of
salivary cortisol concentrations [39]. This seems unlikely
given that the pattern of our results was similar when
we adjusted for negative life events (including neighbor-
hood safety) and depressive symptoms. Additional con-
founding may also arise because pregnancy-induced
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and increase blood Pb levels by releasing bone Pb stores
through bone resorption.
Conclusions
Cortisol awakening response was associated with in-
creased blood Pb concentrations among pregnant women
in this cohort. While many studies of endocrine disruption
have focused on thyroid and gonadal hormones, the
association between other environmental chemicals and
cortisol homeostasis remains unstudied in humans. The
importance of glucocorticoids in brain development and
sensitivity of salivary cortisol levels to a known toxicant
illustrates the importance of understanding how environ-
mental chemicals might impact both cortisol rhythms and
subsequent child health and development.
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